GO:0004658 propionyl-CoA carboxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004658 (propionyl-CoA carboxylase activity) catalyzes the ATP-dependent carboxylation of propanoyl-CoA to (S)-methylmalonyl-CoA, a committed step in propionate catabolism.
• The enzyme is a biotin-dependent, multi-subunit complex typically composed of PCCA (alpha) and PCCB (beta) subunits that assemble into an (αβ)6 dodecamer.
• Loss-of-function variants in PCCA or PCCB cause propionic acidemia, an inherited metabolic disorder with severe neurological and systemic manifestations.
• PCC activity is also relevant to cancer immunometabolism, where PCCB loss alters T cell function in pancreatic cancer models.
• Biotin metabolism and holocarboxylase synthetase are required for PCC activation; biotinidase deficiency can secondarily impair PCC-dependent pathways.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal dissection of PCC subunit function in disease and metabolic engineering.
Description
Propionyl-CoA carboxylase (PCC) activity, encoded by the Gene Ontology term GO:0004658, is a mitochondrial biotin-dependent carboxylase that converts propanoyl-CoA (propionyl-CoA) to (S)-methylmalonyl-CoA using bicarbonate and ATP. This reaction is a critical entry point for the catabolism of odd-chain fatty acids, branched-chain amino acids (isoleucine, valine, methionine, threonine) and cholesterol side-chain oxidation, funneling carbon into the tricarboxylic acid (TCA) cycle via succinyl-CoA. The enzyme is a member of the larger family of biotin-dependent carboxylases and shares mechanistic features with pyruvate carboxylase and 3-methylcrotonyl-CoA carboxylase. From a research perspective, GO:0004658 is central to inherited metabolic disease, metabolic engineering and cancer immunometabolism. Biallelic pathogenic variants in PCCA or PCCB cause propionic acidemia, a disorder characterized by metabolic decompensation, hyperammonemia and cardiomyopathy. Beyond rare disease, PCC activity has been targeted for succinate biosynthesis in microbial systems through directed evolution, and PCCB loss has been linked to impaired anti-tumor T cell responses in pancreatic cancer models. Structural and dynamic studies have begun to resolve the conformational landscape of the human PCC dodecamer, revealing how subunit rearrangements coordinate catalysis. Because PCC sits at the intersection of mitochondrial metabolism, epigenetics (via methylmalonyl-CoA and succinyl-CoA pools) and immune cell function, precise genetic models are needed to determine causality. This article integrates the QuickGO definition of GO:0004658 with verified PubMed literature to summarize its mechanism, associated genes, disease relevance and the CRISPR-based methods used to study it.
propionyl-CoA carboxylase activity At A Glance
| GO ID | GO:0004658 |
|---|---|
| GO term | propionyl-CoA carboxylase activity |
| Ontology | molecular_function |
| Synonym | PCCase activity; propanoyl-CoA:carbon-dioxide ligase (ADP-forming); propionyl coenzyme A carboxylase activity |
| Major function | ATP-dependent carboxylation of propanoyl-CoA to (S)-methylmalonyl-CoA |
| Cofactor | Biotin (covalently attached to the alpha subunit) |
| Substrates | Propanoyl-CoA, bicarbonate (HCO3-), ATP |
| Products | ADP, phosphate, (S)-methylmalonyl-CoA |
| Subcellular location | Mitochondrial matrix |
| Representative genes | PCCA (alpha subunit), PCCB (beta subunit) |
What Is GO:0004658?
GO:0004658, propionyl-CoA carboxylase activity, is defined in QuickGO as the catalysis of the reaction: ATP + propanoyl-CoA + HCO3- = ADP + phosphate + (S)-methylmalonyl-CoA. In other words, the enzyme uses the energy of ATP hydrolysis to attach a carboxyl group (derived from bicarbonate) onto propanoyl-CoA, producing (S)-methylmalonyl-CoA. This is a biotin-dependent carboxylation reaction in which the prosthetic group biotin is covalently attached to the alpha subunit and shuttles activated CO2 between two active sites. The term is classified under molecular_function and is synonymous with PCCase activity, propanoyl-CoA:carbon-dioxide ligase (ADP-forming) and propionyl coenzyme A carboxylase activity.
Why Is propionyl-CoA carboxylase activity Important in Cell Biology?
GO:0004658 is important because it governs a rate-limiting step in propionate catabolism and connects mitochondrial carbon flux to the TCA cycle, amino acid degradation and fatty acid oxidation. Its dysfunction causes propionic acidemia, a life-threatening inherited metabolic disorder, and its activity is also relevant to cancer immunometabolism and microbial succinate production. Understanding PCC at the molecular level informs newborn screening, dietary management, and the design of targeted therapies and metabolic engineering strategies.
• Catalyzes the committed step in propionate catabolism, feeding carbon into the TCA cycle via succinyl-CoA.
• Deficiency of PCCA or PCCB causes propionic acidemia, a severe organic acidemia with neurological and cardiac complications.
• PCC activity is biotin-dependent, linking it to biotin metabolism and multiple carboxylase deficiency states.
• PCCB loss in tumor cells can impair anti-tumor T cell responses in pancreatic cancer models.
• Directed evolution of PCC has been explored to enhance succinate biosynthesis in industrial biotechnology.
• Structural dynamics of the human PCC dodecamer provide a framework for understanding catalytic cooperativity.
• Fasting and dietary interventions modulate metabolic alterations in Pcca-mutant mouse models.
• PCC is a target for newborn screening and genetic diagnosis of inherited metabolic disorders.
• CRISPR models enable causal testing of PCC subunit variants in disease and metabolic engineering.
Molecular Mechanism of propionyl-CoA carboxylase activity
Substrate binding and domain architecture
In simple terms: The enzyme grabs its substrates and holds them in the right position to react.
Propionyl-CoA carboxylase (PCC) is a multi-domain enzyme. The alpha subunit (PCCA) contains a biotin carboxylase (BC) domain and a biotin carboxyl carrier protein (BCCP) domain, while the beta subunit (PCCB) contains a carboxyltransferase (CT) domain. The enzyme assembles into an (αβ)6 dodecamer, and recent structural studies have resolved nanoscale conformational dynamics that coordinate substrate channeling between the BC and CT active sites. Propanoyl-CoA binds at the CT domain, while bicarbonate and ATP bind at the BC domain.
ATP-dependent carboxylation of biotin
In simple terms: The enzyme uses ATP energy to attach a carboxyl group to biotin, a molecular carrier.
In the first half-reaction, the BC domain catalyzes the ATP-dependent carboxylation of the biotin prosthetic group, which is covalently linked to a conserved lysine residue in the BCCP domain. This step consumes ATP and bicarbonate, producing carboxybiotin and ADP plus phosphate. The reaction is analogous to other biotin-dependent carboxylases and requires Mg2+ as a cofactor.
Carboxyl transfer to propanoyl-CoA
In simple terms: The activated carboxyl group is handed off to propanoyl-CoA to make methylmalonyl-CoA.
The BCCP domain swings the carboxybiotin to the CT active site, where the carboxyl group is transferred to propanoyl-CoA, yielding (S)-methylmalonyl-CoA. This product is then converted by methylmalonyl-CoA epimerase and methylmalonyl-CoA mutase to succinyl-CoA, which enters the TCA cycle. The overall reaction is: ATP + propanoyl-CoA + HCO3- = ADP + phosphate + (S)-methylmalonyl-CoA, as defined in GO:0004658.
Conformational dynamics and regulation
In simple terms: The enzyme changes shape to coordinate its two active sites and is regulated by its environment.
Recent nanoscale conformational dynamics studies of human PCC have revealed that the dodecamer undergoes coordinated motions that facilitate substrate channeling and catalysis. PCC activity is regulated by biotin availability and holocarboxylase synthetase-mediated biotinylation. Inborn errors in biotin metabolism, such as biotinidase deficiency, can secondarily reduce PCC activity and cause multiple carboxylase deficiency. Additionally, metabolic states such as fasting can modulate PCC-related pathways in vivo.
Key Genes Involved in GO:0004658 propionyl-CoA carboxylase activity
The genes and proteins most directly associated with GO:0004658 include the structural subunits of propionyl-CoA carboxylase, enzymes that modify its biotin cofactor, and downstream metabolic partners.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCCA | Encodes the alpha subunit containing biotin carboxylase and biotin carboxyl carrier domains | Mutations cause propionic acidemia; target for structural and functional studies |
| PCCB | Encodes the beta subunit containing the carboxyltransferase domain | Mutations cause propionic acidemia; linked to anti-tumor T cell function |
| HLCS | Holocarboxylase synthetase; attaches biotin to PCC and other carboxylases | Defects cause multiple carboxylase deficiency affecting PCC activity |
| BTD | Biotinidase; recycles biotin for carboxylase activation | Deficiency impairs PCC and other biotin-dependent enzymes |
| MUT | Methylmalonyl-CoA mutase; converts methylmalonyl-CoA to succinyl-CoA downstream of PCC | Defects cause methylmalonic acidemia; relevant to PCC pathway flux |
| MCEE | Methylmalonyl-CoA epimerase; interconverts methylmalonyl-CoA stereoisomers | Downstream enzyme in propionate catabolism |
| ACACA | Acetyl-CoA carboxylase alpha; related biotin-dependent carboxylase | Comparative studies of carboxylase deficiency |
| ACACB | Acetyl-CoA carboxylase beta; related biotin-dependent carboxylase | Comparative studies of carboxylase deficiency |
| PC | Pyruvate carboxylase; biotin-dependent enzyme in gluconeogenesis | Shared biotinylation machinery with PCC |
| MCCC1 | 3-methylcrotonyl-CoA carboxylase subunit 1; biotin-dependent enzyme | Comparative biotin-dependent carboxylase biology |
| MCCC2 | 3-methylcrotonyl-CoA carboxylase subunit 2 | Comparative biotin-dependent carboxylase biology |
| SUCLA2 | Succinyl-CoA ligase subunit; downstream of PCC in TCA cycle | Links PCC flux to mitochondrial energy metabolism |
| SUCLG1 | Succinyl-CoA ligase subunit; downstream of PCC | Links PCC flux to mitochondrial energy metabolism |
| SLC25A1 | Mitochondrial citrate carrier; related to TCA flux | Context for metabolic modeling |
| PPARGC1A | PGC-1alpha; regulator of mitochondrial biogenesis | Potential modifier of PCC pathway capacity |
| SIRT3 | Mitochondrial deacetylase; regulates metabolic enzymes | Potential regulator of PCC-related metabolism |
How Is propionyl-CoA carboxylase activity Regulated?
Propionyl-CoA carboxylase activity is regulated at multiple levels. Its catalytic function requires post-translational biotinylation by holocarboxylase synthetase (HLCS), and biotin availability is maintained by biotinidase (BTD); defects in either gene reduce PCC activity and cause multiple carboxylase deficiency. At the metabolic level, substrate supply from odd-chain fatty acids and branched-chain amino acids influences flux through PCC, and fasting has been shown to alleviate metabolic alterations in Pcca-mutant mice, indicating that nutritional state modulates the pathway. Transcriptional and mitochondrial biogenesis programs may also influence PCC capacity, though direct transcriptional regulation of PCCA and PCCB is less well characterized.
propionyl-CoA carboxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCCA | Propionic acidemia | Pcca knockout or point-mutation mouse models; patient-derived fibroblasts |
| PCCB | Propionic acidemia; anti-tumor T cell regulation | Pccb knockout mice; pancreatic cancer models |
| HLCS | Holocarboxylase synthetase deficiency (multiple carboxylase deficiency) | Hlcs knockout or point-mutation cell models |
| BTD | Biotinidase deficiency | Btd knockout models; enzymatic assays |
| MUT | Methylmalonic acidemia | Mut knockout mice; metabolic flux studies |
Propionic acidemia
Biallelic pathogenic variants in PCCA or PCCB cause propionic acidemia, an autosomal recessive organic acidemia characterized by vomiting, lethargy, metabolic acidosis, hyperammonemia, cardiomyopathy and developmental delay. The disease results from deficient PCC activity, leading to accumulation of propionyl-CoA and its toxic metabolites. Newborn screening and confirmatory enzymatic or genetic testing are standard diagnostic approaches.
Multiple carboxylase deficiency and biotin disorders
Because PCC requires biotinylation for activity, disorders of biotin metabolism such as holocarboxylase synthetase deficiency and biotinidase deficiency can cause secondary PCC deficiency, presenting as multiple carboxylase deficiency. Deficient acetyl-CoA carboxylase activity has been documented in multiple carboxylase deficiency, illustrating the shared biotin-dependent enzyme network.
Cancer immunometabolism
Recent work in a pancreatic cancer mouse model showed that loss of propionyl-CoA carboxylase subunit B (PCCB) regulates anti-tumor T cells, suggesting that PCC activity in tumor or immune cells can influence cancer immunity. This highlights a non-canonical role for PCC beyond inherited metabolic disease.
Metabolic engineering and succinate biosynthesis
Directed evolution of propionyl-CoA carboxylase has been explored to enhance succinate biosynthesis, demonstrating that PCC activity can be engineered for industrial biotechnology applications. This connects GO:0004658 to synthetic biology and metabolic pathway optimization.
From propionyl-CoA carboxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PCCA abolish PCC activity and cause metabolic decompensation? | PCCA knockout cell lines and mouse models |
| How do specific missense variants affect PCC stability and catalysis? | Point-mutation knock-in models expressing patient variants |
| Can tagged PCC subunits be used to study assembly and dynamics? | Knock-in of epitope-tagged PCCA or PCCB |
| Does PCCB overexpression alter T cell function in tumors? | Overexpression models in cancer cell lines or T cells |
| Can engineered PCC improve succinate production? | Directed evolution and overexpression in microbial or mammalian cells |
| How does fasting modulate PCC-related metabolic alterations? | Pcca mutant mice subjected to dietary intervention |
How to Study the propionyl-CoA carboxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic carboxylation assay | PCC catalytic activity | Diagnosis and functional validation |
| Cryo-EM | Three-dimensional structure and conformational states | Mechanistic studies of PCC assembly |
| Hydrogen-deuterium exchange MS | Conformational dynamics | Mapping subunit motions |
| Metabolomics (LC-MS/MS) | Propionylcarnitine, methylmalonic acid, amino acids | Disease monitoring and flux analysis |
| CRISPR knockout screening | Gene essentiality and modifiers | Identifying PCC pathway regulators |
| Directed evolution | Improved enzyme variants | Metabolic engineering for succinate |
| Western blot | Protein expression and biotinylation | Assessing PCC subunit levels |
| Mouse metabolic phenotyping | In vivo metabolic alterations | Testing dietary interventions |
Enzymatic activity assays
PCC activity can be measured radiometrically or spectrophotometrically by monitoring the carboxylation of propanoyl-CoA to methylmalonyl-CoA. These assays are used in clinical diagnosis of propionic acidemia and in functional validation of CRISPR-edited cell lines.
Structural and biophysical methods
Cryo-electron microscopy and hydrogen-deuterium exchange mass spectrometry have been used to resolve the nanoscale conformational dynamics of human PCC, revealing how subunit motions coordinate catalysis. These methods are essential for understanding variant effects on assembly and function.
Metabolic flux and metabolomics
Mass spectrometry-based metabolomics can quantify propionylcarnitine, methylmalonic acid and related metabolites to assess PCC pathway flux in cells and animal models. Fasting studies in Pcca-mutant mice illustrate how dietary state alters metabolic profiles.
Genetic and CRISPR screening
CRISPR knockout and point-mutation screens can identify modifiers of PCC activity and its downstream effects. Directed evolution studies have used mutagenesis and selection to improve PCC function for succinate biosynthesis.
How CRISPR Can Be Used to Study GO:0004658 propionyl-CoA carboxylase activity
Knockout
CRISPR knockout of PCCA or PCCB can abolish PCC activity, creating cellular and animal models of propionic acidemia. These models are used to study metabolic decompensation, test therapeutic strategies and validate downstream metabolic effects.
Point Mutation
Point-mutation knock-in models can recapitulate specific patient variants in PCCA or PCCB, allowing researchers to assess variant-specific effects on enzyme stability, activity and disease severity.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous PCCA or PCCB loci enables live-cell imaging and proteomic analysis of PCC assembly and dynamics.
Overexpression
Overexpression of wild-type or engineered PCC subunits can enhance flux through propionate catabolism and has been explored for succinate biosynthesis and cancer immunometabolism studies.
How EDITGENE Supports propionyl-CoA carboxylase activity Research
Researchers studying propionyl-CoA carboxylase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic flux, disease phenotypes or immune cell function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models for such studies.
Contact EDITGENE today to design your custom CRISPR model for propionyl-CoA carboxylase activity research.
Frequently Asked Questions About propionyl-CoA carboxylase activity
What is propionyl-CoA carboxylase activity?
Propionyl-CoA carboxylase activity (GO:0004658) is the ATP-dependent carboxylation of propanoyl-CoA to (S)-methylmalonyl-CoA, a key step in propionate catabolism.
What genes are involved in propionyl-CoA carboxylase activity?
The core genes are PCCA and PCCB, which encode the alpha and beta subunits of the PCC enzyme complex.
What diseases are associated with propionyl-CoA carboxylase deficiency?
Deficiency causes propionic acidemia, and secondary impairment occurs in biotin metabolism disorders such as holocarboxylase synthetase deficiency and biotinidase deficiency.
Where does propionyl-CoA carboxylase act in the cell?
PCC is located in the mitochondrial matrix, where it participates in propionate catabolism and TCA cycle anaplerosis.
What cofactors does propionyl-CoA carboxylase require?
PCC requires biotin as a covalently bound prosthetic group and Mg2+ for ATP-dependent carboxylation.
How is propionyl-CoA carboxylase activity measured?
Enzymatic assays measuring the conversion of propanoyl-CoA to methylmalonyl-CoA, often using radiolabeled or spectrophotometric methods, are standard.
Can CRISPR be used to study propionyl-CoA carboxylase?
Yes, CRISPR knockout, point-mutation and knock-in models are widely used to study PCC subunit function and disease mechanisms.
What is the role of PCCB in cancer?
PCCB loss has been shown to regulate anti-tumor T cells in a pancreatic cancer mouse model, suggesting a role in cancer immunometabolism.
How does fasting affect propionyl-CoA carboxylase deficiency?
Fasting has been shown to alleviate metabolic alterations in mice with Pcca mutation, indicating that nutritional state modulates the disease.
Can propionyl-CoA carboxylase be engineered for biotechnology?
Directed evolution of PCC has been explored to enhance succinate biosynthesis, demonstrating its potential in metabolic engineering.
Conclusion
GO:0004658, propionyl-CoA carboxylase activity, represents a central enzymatic step in mitochondrial propionate catabolism with broad relevance to inherited metabolic disease, cancer immunometabolism and metabolic engineering. The enzyme's biotin-dependent mechanism, multi-subunit architecture and conformational dynamics are increasingly well understood through structural and genetic studies. CRISPR-based models provide powerful tools to dissect the causal roles of PCCA, PCCB and related genes in health and disease. Continued research into PCC biology will inform therapeutic strategies for propionic acidemia and other metabolic disorders.
References
- 1. Wongkittichote P et al.. 2017. Propionyl-CoA carboxylase - A review.. Mol Genet Metab 122(4):145-152 PMID: 29033250
- 2. Liu Y et al.. 2021. Directed Evolution of Propionyl-CoA Carboxylase for Succinate Biosynthesis.. Trends Biotechnol 39(4):330-331 PMID: 33632542
- 3. Adam MP et al.. 1993. Propionic Acidemia.. PMID: 22593918
- 4. Yan H et al.. 2026. Nanoscale conformational dynamics of human propionyl-CoA carboxylase.. Structure 34(1):62-75.e4 PMID: 41197621
- 5. Han HV et al.. 2024. Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model.. bioRxiv PMID: 37546948
- 6. Woodliff B et al.. 2026. Biotinidase Deficiency.. PMID: 32809442
- 7. Feldman GL et al.. 1981. Deficient acetyl CoA carboxylase activity in multiple carboxylase deficiency.. Clin Chim Acta 111(2-3):147-51 PMID: 6112081
- 8. He W et al.. 2024. Fasting alleviates metabolic alterations in mice with propionyl-CoA carboxylase deficiency due to Pcca mutation.. Commun Biol 7(1):659 PMID: 38811689
